28 Oct Advanced Technology Consortium to implement TeraMedica's clinical enterprise suite
Milwaukee, Wis. – TeraMedica and the Advanced Technology Consortium have signed an agreement to implement the Evercore clinical enterprise suite to serve as the DICOM archive for diagnostic imaging, DICOM RT, and meta-data related to the diagnosis, treatment, and outcomes assessment for radiation oncology clinical trial protocol patient data sets.
The ATC is supported by a National Cancer Institute grant to Washington University. The ATC functions as a “virtual entity” made up of the nation’s radiation oncology clinical trials QA Centers, including the: (1) Image-Guided Therapy QA Center (ITC) located at – Washington University in St. Louis and UC Davis; (2) Radiation Therapy Oncology Group (RTOG) Headquarters Dosimetry Group, (3) Radiological Physics Center (RPC, M.D. Anderson Cancer Center), and (4) Quality Assurance Review Center (QARC, University of Massachusetts).
Under the terms of the agreement, TeraMedica’s Evercore – Clinical Enterprise Suite will be implemented first at the ITC at Washington University in St. Louis. “This is a very important step forward for ATC in meeting the needs of radiation oncology advanced technology clinical trials,” said Dr. James Purdy, Principal Investigator for the ATC grant. “With the emergence of new imaging and radiotherapy treatment modalities has come the need to test these techniques in clinical trials.
“Functional imaging for target definition and response assessment, 4-D imaging for motion assessment, 2-D and 3-D image-guided treatment delivery, and adaptive radiotherapy techniques represent new sources of data that must be reviewed and analyzed for these trials.”
To manage the collection and evaluation of these new data objects, the TeraMedica Evercore software will provide the archival storage and relational database needed for all ATC supported protocol patient case data sets including diagnostic images, DICOM RT objects, and associated meta-data.”
“We are very excited about the opportunity to positively impact cancer-related clinical trials and procedural capability and efficiency at the ITC ” said Jim Prekop, TeraMedica Healthcare Technology CEO. He added, “Together we can deliver enhancements in data management for radiation oncology clinical trials at the ITC and eventually the national cancer clinical trial network.”
Prekop echoed Dr. Purdy’s sentiments, saying, “The Cancer Clinical Trial domain faces significant data integration challenges. The Evercore – Clinical Enterprise Suite’s ability to efficiently coalesce protocol data objects in a central clinical content manager while also satisfying the QA Centers’ need for a holistic view of the protocol case data in near real time means everyone wins.”
About TeraMedica Healthcare Technology
TeraMedica provides medical informatics that will transform the doctor and patient relationship. TeraMedica offers a broad range of software that collects digital medical images from diverse data sources across vast health care systems and manages them in a single patient snapshot.
The Advanced Technology Consortium (ATC) for Clinical Trials Quality Assurance is supported by a National Cancer Institute U24 grant to Washington University. The ATC capitalizes on the existing infrastructure and strengths of national QA programs. Its overall mission is to facilitate and support NCI sponsored advanced technology clinical trials in radiation oncology, particularly those requiring digital data submission. The ATC’s ultimate goal is to improve the standards of care in the management of cancer by improving the quality of clinical trials medicine.